Noninvasive Evaluation of Renal Allograft Fibrosis by MRI

NCT04899167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-10-05

No results posted yet for this study

Summary

The purpose of this study is to validate an MRI method to detect renal fibrosis in patients after kidney transplantation (KT).

Conditions

  • Kidney Transplantation

Interventions

OTHER

MRI 1.5T and 3.0T

Magnetic Resonance Imaging for Renal Fibrosis

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Lilach Lerman, MD, PhD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899167 on ClinicalTrials.gov